Literature DB >> 19740484

Cardiovascular autonomic dysfunction in Parkinson's disease.

Tjalf Ziemssen1, Heinz Reichmann.   

Abstract

Symptoms of cardiovascular dysautonomia are a common occurrence in Parkinson's disease (PD). In addition to this dysautonomia as part of PD itself, dysfunction of the autonomic nervous system (ANS) can be triggered as a side-effect of drug treatment interacting with the ANS or - if prominent and early - an indication of a different disease such as multiple system atrophy (MSA). Various diagnostic tests are available to demonstrate autonomic failure. While autonomic function tests can differentiate parasympathetic from sympathetic dysfunction, cardiac imaging can define the pathophysiologically involved site of a lesion. Standard tests such as 24-h ambulatory blood pressure measurements can identify significant autonomic failure which needs treatment. The most frequent and disturbing symptom of cardiovascular autonomic dysfunction is orthostatic hypotension. Symptoms include generalized weakness, light-headiness, mental "clouding" up to syncope. Factors like heat, food, alcohol, exercise, activities which increase intrathoraric pressure (e.g. defecation, coughing) and certain drugs (e.g. vasodilators) can worsen a probably asymptomatic orthostatic hypotension. Non-medical and medical therapies can help the patient to cope with a disabling symptomatic orthostatic hypotension. Supine hypertension is often associated with orthostatic hypotension. The prognostic role of cardiovagal and baroreflex dysfunction is still not yet known.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740484     DOI: 10.1016/j.jns.2009.08.031

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  35 in total

Review 1.  Evolving concepts in neurogenic osteoporosis.

Authors:  Weiping Qin; William A Bauman; Christopher P Cardozo
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

2.  Non-motor Symptoms in Patients with Parkinson's Disease: A Cross-sectional Survey.

Authors:  Khushbakht Tanveer; Immad Attique; Waleed Sadiq; Arsalan Ahmad
Journal:  Cureus       Date:  2018-10-04

Review 3.  Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.

Authors:  L David Willison; Takashi Kudo; Dawn H Loh; Dika Kuljis; Christopher S Colwell
Journal:  Exp Neurol       Date:  2013-01-24       Impact factor: 5.330

Review 4.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Gerd Fuchs; Wolfgang Greulich; Heinz Reichmann; Michael Schwarz; Birgit Herting
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

Review 5.  Cold pressor test in spinal cord injury-revisited.

Authors:  Michèle Hubli; Doris Bolt; Andrei V Krassioukov
Journal:  Spinal Cord       Date:  2017-12-20       Impact factor: 2.772

6.  Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype.

Authors:  Paolo Solla; Christian Cadeddu; Antonino Cannas; Martino Deidda; Nicola Mura; Giuseppe Mercuro; Francesco Marrosu
Journal:  J Neural Transm (Vienna)       Date:  2015-03-24       Impact factor: 3.575

7.  α-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits.

Authors:  Penelope J Hallett; Jesse R McLean; Andrew Kartunen; J William Langston; Ole Isacson
Journal:  Neurobiol Dis       Date:  2012-04-19       Impact factor: 5.996

8.  Mortality and prognosis in patients with neurogenic orthostatic hypotension.

Authors:  Simona Maule; Valeria Milazzo; Milena Maria Maule; Cristina Di Stefano; Alberto Milan; Franco Veglio
Journal:  Funct Neurol       Date:  2012 Apr-Jun

9.  Time- and frequency-domain parameters of heart rate variability and sympathetic skin response in Parkinson's disease.

Authors:  Walter Maetzler; Marie Karam; Monika Fruhmann Berger; Tanja Heger; Corina Maetzler; Heinz Ruediger; Juliana Bronzova; Patricia Pita Lobo; Joaquim J Ferreira; Tjalf Ziemssen; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2014-07-20       Impact factor: 3.575

10.  [Syncope from the viewpoint of a neurologist].

Authors:  A Bickel; J Röther
Journal:  Herz       Date:  2014-06       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.